tiprankstipranks
Medipower (Overseas) Public Co. Limited. (IL:MDPR)
TASE:MDPR
Israel Market
MDPR
Medipower 0.1$
RESEARCH TOOLSreports

Medipower 0.1$ (MDPR) Ratios

0 Followers

Medipower 0.1$ Ratios

IL:MDPR's free cash flow for Q2 2026 was $0.69. For the 2026 fiscal year, IL:MDPR's free cash flow was decreased by $ and operating cash flow was $0.65. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.94 2.67 0.00 2.91 2.59
Quick Ratio
 0.94 2.67 0.00 2.91 2.59
Cash Ratio
 0.76 2.57 0.00 2.91 2.59
Solvency Ratio
 -0.01 0.04 0.04 -0.06 -0.07
Operating Cash Flow Ratio
 0.36 0.61 0.00 6.56 4.76
Short-Term Operating Cash Flow Coverage
 0.45 0.61 0.00 0.00 0.00
Net Current Asset Value
$ -479.19M$ -303.46M$ -224.83M$ -269.88M$ -281.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.67 0.64 0.56 0.57 0.60
Debt-to-Equity Ratio
 3.43 2.40 1.74 1.91 2.20
Debt-to-Capital Ratio
 0.77 0.71 0.64 0.66 0.69
Long-Term Debt-to-Capital Ratio
 0.76 0.69 0.64 0.66 0.69
Financial Leverage Ratio
 5.09 3.75 3.12 3.37 3.68
Debt Service Coverage Ratio
 0.47 0.73 9.19 0.00 0.00
Interest Coverage Ratio
 2.11 2.13 2.59 0.00 0.00
Debt to Market Cap
 5.87 3.18 2.60 2.84 3.03
Interest Debt Per Share
 9.78 7.12 4.74 4.62 4.95
Net Debt to EBITDA
 16.39 7.50 2.40 -17.10 -12.65
Profitability Margins
Gross Profit Margin
66.82%66.80%100.00%100.00%100.00%
EBIT Margin
76.61%82.40%0.00%0.00%0.00%
EBITDA Margin
56.19%82.40%241.46%-34.96%-51.43%
Operating Profit Margin
59.90%60.19%65.44%48.47%42.16%
Pretax Profit Margin
28.80%54.14%39.33%26.63%17.17%
Net Profit Margin
9.32%30.07%26.00%20.72%3.58%
Continuous Operations Profit Margin
15.99%39.40%30.31%21.28%11.92%
Net Income Per EBT
32.37%55.54%66.09%77.83%20.87%
EBT Per EBIT
48.08%89.95%60.10%54.94%40.73%
Return on Assets (ROA)
0.64%2.45%2.45%1.92%0.32%
Return on Equity (ROE)
3.21%9.20%7.64%6.48%1.18%
Return on Capital Employed (ROCE)
4.35%5.19%6.16%4.51%3.79%
Return on Invested Capital (ROIC)
2.31%3.58%4.33%3.61%2.88%
Return on Tangible Assets
0.64%2.45%2.45%1.92%0.32%
Earnings Yield
5.57%12.16%11.37%9.62%1.62%
Efficiency Ratios
Receivables Turnover
 28.90 14.94 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.07 77.88 0.10 0.10 0.10
Asset Turnover
 0.07 0.08 0.09 0.09 0.09
Working Capital Turnover Ratio
 6.19 1.01 1.80 9.88 11.90
Cash Conversion Cycle
 12.63 24.43 0.00 0.00 0.00
Days of Sales Outstanding
 12.63 24.43 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 12.63 24.43 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 0.28 0.35 0.31 0.23 0.25
Free Cash Flow Per Share
 0.28 0.35 0.31 0.23 0.25
CapEx Per Share
 0.00 0.00 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 153.90
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 153.90
Operating Cash Flow Coverage Ratio
 0.03 0.05 0.07 0.05 0.05
Operating Cash Flow to Sales Ratio
 0.29 0.40 0.40 0.31 0.34
Free Cash Flow Yield
17.21%16.07%17.70%14.43%15.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.75 8.33 8.75 10.39 61.65
Price-to-Sales (P/S) Ratio
 1.67 2.47 2.29 2.15 2.21
Price-to-Book (P/B) Ratio
 0.58 0.76 0.67 0.67 0.73
Price-to-Free Cash Flow (P/FCF) Ratio
 5.81 6.22 5.65 6.93 6.46
Price-to-Operating Cash Flow Ratio
 5.81 6.22 5.65 6.93 6.41
Price-to-Earnings Growth (PEG) Ratio
 -0.41 0.28 0.35 0.02 -0.70
Price-to-Fair Value
 0.58 0.76 0.67 0.67 0.73
Enterprise Value Multiple
 19.37 10.50 3.35 -23.27 -16.94
Enterprise Value
 538.57M 387.72M 316.44M 314.13M 327.09M
EV to EBITDA
 19.37 10.50 3.35 -23.27 -16.94
EV to Sales
 10.89 8.66 8.08 8.13 8.71
EV to Free Cash Flow
 37.78 21.78 19.96 26.18 25.47
EV to Operating Cash Flow
 37.78 21.78 19.96 26.18 25.30
Tangible Book Value Per Share
 4.00 3.28 2.96 2.76 2.60
Shareholders’ Equity Per Share
 2.77 2.86 2.60 2.42 2.25
Tax and Other Ratios
Effective Tax Rate
 0.44 0.27 0.23 0.20 0.31
Revenue Per Share
 0.97 0.88 0.77 0.76 0.74
Net Income Per Share
 0.09 0.26 0.20 0.16 0.03
Tax Burden
 0.32 0.56 0.66 0.78 0.21
Interest Burden
 0.38 0.66 0.00 0.00 0.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.01 0.00 0.07 0.07 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 3.09 1.32 1.56 1.50 9.61
Currency in USD